Frontiers in Endocrinology (Oct 2019)

Protease-Activated Receptors in the Intestine: Focus on Inflammation and Cancer

  • Morgane Sébert,
  • Nuria Sola-Tapias,
  • Emmanuel Mas,
  • Frédérick Barreau,
  • Audrey Ferrand

DOI
https://doi.org/10.3389/fendo.2019.00717
Journal volume & issue
Vol. 10

Abstract

Read online

Protease-activated receptors (PARs) belong to the G protein-coupled receptor (GPCR) family. Compared to other GPCRs, the specificity of the four PARs is the lack of physiologically soluble ligands able to induce their activation. Indeed, PARs are physiologically activated after proteolytic cleavage of their N-terminal domain by proteases. The resulting N-terminal end becomes a tethered activation ligand that interact with the extracellular loop 2 domain and thus induce PAR signal. PARs expression is ubiquitous and these receptors have been largely described in chronic inflammatory diseases and cancer. In this review, after describing their discovery, structure, mechanisms of activation, we then focus on the roles of PARs in the intestine and the two main diseases affecting the organ, namely inflammatory bowel diseases and cancer.

Keywords